Comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Hormone-related crisis | May cause cortisol deficiency and salt-wasting crisis, especially in infancy. | Not characterized by adrenal hormone crisis in the supplied description. | High |
| Genital development | Ambiguous genitalia may occur because of prenatal androgen excess. | Genital ambiguity is not an established feature from the supplied data. | High |
| Development and learning | Growth issues may occur; primary developmental delay is not established here. | Developmental delay, learning difficulty, and sometimes autism traits may occur. | Moderate |
When to favor each condition
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Infant with suspected adrenal insufficiency
Salt-wasting or cortisol deficiency points toward an endocrine disorder needing urgent assessment.
High
Atypical genital appearance at birth
This can fit androgen-related effects of 21-hydroxylase deficiency, but confirmation is required.
Moderate
Abnormal adrenal steroid testing
A compatible hormone pattern supports further endocrine and genetic evaluation.
Moderate
Choose 15q11q13 Microduplication Syndrome C2675336 when
Early developmental delay
Delay beginning in early childhood fits the described chromosomal condition better than isolated adrenal disease.
Moderate
Learning or autism-spectrum concerns
These features are described for 15q11q13 duplication and warrant genetic assessment.
Moderate
Microarray suggests 15q11q13 duplication
A relevant chromosomal finding directly supports this diagnosis over CAH.
High
How key tests differ
| Test | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Adrenal steroid profile | May show a pattern consistent with 21-hydroxylase deficiency; cutoffs are not stated here. | No characteristic adrenal steroid abnormality is established by the supplied data. | An abnormal result suggests endocrine disease but is not itself a complete diagnosis. |
| Electrolytes during illness | Salt-wasting crisis may involve sodium and potassium abnormalities. | Electrolyte crisis is not a described feature. | Abnormal electrolytes require urgent clinical correlation and do not prove the cause. |
| Genetic testing | CYP21A2-related testing may confirm the endocrine diagnosis. | Chromosomal microarray or equivalent testing may detect 15q11q13 duplication. | The appropriate genetic test depends on the suspected mechanism. |
Prognosis comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- Chronic and potentially severe, with crisis risk; exact survival or complication rates are not established here.
- Factors
- Hormone control, illness management, and early recognition may influence course.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Chronic and generally described as moderate, with variable developmental impact.
- Factors
- Support, learning needs, and associated features may influence function.
Time frame: Both may require long-term follow-up from infancy or early childhood.
Individual prognosis is not established from these summaries and needs specialist interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Acute decompensation | Adrenal crisis and salt wasting can be medical emergencies. Acute endocrine decompensation is not established here. Emergency care should be guided by the presenting physiology. |
| Growth and development | Growth issues may occur alongside hormone imbalance. Developmental and learning difficulties are central described concerns. Monitoring needs differ between endocrine and neurodevelopmental effects. |
| Long-term management burden | Lifelong hormone replacement is described. Supportive therapies are used to manage symptoms. Neither description establishes exact treatment intensity or outcome. |
Patient education highlights
- HighDifferent causes
One condition affects adrenal hormones; the other is a chromosomal duplication with developmental features.
- HighUrgent symptoms
Vomiting, lethargy, dehydration, or collapse in suspected CAH needs urgent medical care.
- MediumConfirmation
A test abnormality or developmental concern should be interpreted by a clinician before labeling a diagnosis.